Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. (Q51809320)
Jump to navigation
Jump to search
scientific article published on 15 February 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. |
scientific article published on 15 February 2009 |
Statements
1 reference
Administration of a monomeric CCL2 variant to EAE mice inhibits inflammatory cell recruitment and protects from demyelination and axonal loss. (English)
1 reference
1 reference
E Brini
1 reference
F Ruffini
1 reference
A Bergami
1 reference
E Brambilla
1 reference
G Dati
1 reference
B Greco
1 reference
R Cirillo
1 reference
A E I Proudfoot
1 reference
G Comi
1 reference
P Zaratin
1 reference
G Martino
1 reference
15 February 2009
1 reference
209
1 reference
1-2
1 reference
33-39
1 reference
Identifiers
1 reference